Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist
- PMID: 34424560
- PMCID: PMC8616841
- DOI: 10.1002/ajh.26328
Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist
Abstract
A hematologist receives a call from a maternal-fetal medicine (MFM) physician about a previously healthy patient who became ill at 25 weeks' gestation. Her mental status is deteriorating. There are signs of fetal distress. Platelet count and hemoglobin are falling. The MFM physician is considering the hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome. For the hematologist, everything seems unfamiliar. Our goal is to provide hematologists with the fundamental knowledge required for understanding and managing these patients who become suddenly and seriously ill during pregnancy and in whom thrombocytopenia and microangiopathic hemolytic anemia are part of their presentation.
© 2021 Wiley Periodicals LLC.
Figures
References
-
- Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 202. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2019;133:e1–e25.
-
- Joueidi Y, Peoc’h K, Le Louis M, et al. Maternal and neonatal outcomes and prognostic factors in acute fatty liverof pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020;252:198–205. - PubMed
-
- Ernst LM. Maternal vascular malperfusion of the placental bed. APMIS. 2018;126:551–560. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous